Osteochondrodysplasia Occurring in Transgenic Mice Expressing Interferon-γ
Open Access
- 1 September 1997
- journal article
- research article
- Published by SAGE Publications in Veterinary Pathology
- Vol. 34 (5) , 431-441
- https://doi.org/10.1177/030098589703400507
Abstract
In addition to various biological activities, interferon-γ (IFN-γ) inhibits bone resorption and collagen synthesis. We produced a transgenic mouse line expressing the murine IFN-γ gene and protein in the bone marrow and thymus. Forty-five transgenic FVB/NCr mice, 23 days-9 months of age, were studied for anomalies in the skeletal system. The transgenic mice had short, wide, and deformed long bones. Young transgenic mice had epiphyseal plates severely thickened with zones of hypertrophy and degeneration with irregular metaphyseal borders. Cartilagenous masses were also observed in the metadiaphyseal marrow cavities. These lesions were primarily seen in long bones and ribs. Adult transgenic mice had residues of degenerated cartilagenous masses in the diaphyses. Many osteoclasts with well-developed ruffled borders were present on the metaphyseal cartilagenous masses in young transgenic mice. Adult transgenic mice had less prominent primary spongiosa with fewer osteoclasts at the metaphysis as compared with nontransgenic controls. The cortical bones of the transgenic mice were thinner and more immature compared with controls. Transgenic mice also had fractures, disruption of the epiphyseal plate, and degeneration of articular cartilage. Thus, the IFN-γ transgenic mice developed a complex chondro-osseous lesion that was diagnosed as osteochondrodysplasia. The lesions may originate from primarily decreased matrix synthesis in bone and cartilage and also possible osteoclast-related changes caused by IFN-γ overexpression in the bone marrow. Our IFN-γ transgenic mouse will be a useful model to investigate the role of IFN-γ in bone metabolism.Keywords
This publication has 38 references indexed in Scilit:
- Cartilage collagens: strategies for the study of their organisation and expression in the extracellular matrix.Annals of the Rheumatic Diseases, 1994
- Type II Collagen Mutations in Rare and CommonAnnals of Medicine, 1994
- Transgenic mice carrying interferon genesMolecular Reproduction and Development, 1993
- Transgenic mice expressing a partially deleted gene for type I procollagen (COL1A1). A breeding line with a phenotype of spontaneous fractures and decreased bone collagen and mineral.Journal of Clinical Investigation, 1993
- Interleukin-4 as a potent inhibitor of bone resorptionBiochemical and Biophysical Research Communications, 1990
- Gamma interferon inhibits basal and interleukin 1-induced prostaglandin production and bone resorption in neonatal mouse calvariaBiochemical and Biophysical Research Communications, 1987
- Preferential inhibition of cytokine-stimulated bone resorption by recombinant interferon gammaJournal of Bone and Mineral Research, 1986
- Recombinant γ‐interferon inhibits prostaglandin‐mediated and parathyroid hormone‐induced bone resorption in cultured neonatal mouse calvariaFEBS Letters, 1985
- Immune interferon: a pleiotropic lymphokine with multiple effectsImmunology Today, 1985
- Immune interferon inhibits collagen synthesis by rheumatoid synovial cells associated wth decreaded levels of the procollagen mRNAs(FEBS 2156)FEBS Letters, 1985